Begin main content

Reports

We found 5188 result(s)

fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta)

Last Updated: September 19, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: fluticasone furoate umeclidinium vilanterol
Indications: Chronic obstructive pulmonary disease (COPD)

  • Brand Name: Trelegy Ellipta
  • Manufacturer: GlaxoSmithKline Inc.
  • Project Number: SR0562-000
  • Project Status: Complete
  • Submission Type: NewCombination

Tags

COPD, Pulmonary Disease, Chronic Obstructive, COPD, Respiratory, COPD; emphysema; Trelegy ellipta; fluticasone furoate umeclidinium vilanterol

risankizumab (TBC)

Last Updated: September 19, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: risankizumab
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: TBC
  • Manufacturer: AbbVie Corporation
  • Project Number: SR0583-000
  • Project Status: Pending
  • Submission Type: New

Tags

Dermatology, Dermatology

eluxadoline (Viberzi)

Last Updated: September 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: eluxadoline
Indications: Irritable bowel syndrome with diarrhea

  • Brand Name: Viberzi
  • Manufacturer: Allergan Pharma Co.
  • Project Number: SR0560-000
  • Project Status: Complete
  • Submission Type: New

Tags

Digestive System, Gastrointestinal Tract, Diarrhea, Irritable Bowel Syndrome, Digestive system, Gastrointestinal tract, irritable bowel; Diarrhea

Levodopa / carbidopa (Drug Plan Submission) (Duodopa )

Last Updated: September 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Levodopa / carbidopa (Drug Plan Submission)
Indications: Parkinson's disease

  • Brand Name: Duodopa
  • Manufacturer: AbbVie Corporation
  • Project Number: SR0557-000
  • Project Status: Complete
  • Submission Type: Resubmission

Tags

Nervous System, Carbidopa, Gels, Infusions, Parenteral, Levodopa, Parkinson Disease, Nervous system, Parkinson, Duodopa; duopa; Parkinson disease

Policies on the Appropriate Use of Biosimilar Drugs for Oncology Indications

Published on: September 18, 2018
Result type: Reports
Product Line: Environmental Scans

Biosimilar drugs indicated for the treatment of cancer are emerging in Canada. As these drugs cannot be considered direct replacements for the innovator biologics they are based on, their adoption in clinical practice is not straightforward. Public payers and regulators can help manage the use of oncology biosimilars by providing guidance and po...

  • Project Number: ES0333-000

buprenorphine hydrochloride (Probuphine)

Last Updated: September 17, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: buprenorphine hydrochloride
Indications: Opioid drug dependence, treatment

  • Brand Name: Probuphine
  • Manufacturer: Knight Therapeutics Inc.
  • Project Number: SR0550-000
  • Project Status: Complete
  • Submission Type: New

Tags

Mental Health, Drug Implants, Opioid-Related Disorders, Addiction, Mental health, Probuphine; buprenorphine hydrochloride